A retrospective analysis of practical benefits and caveats of the new WHO 2021 central nervous system tumor classification scheme in low-resource settings: "A perspective from low- and middle-income countries".

Köy, Yazgi; Ceylan, Onur; Kahraman, Asli; Cangi, Sibel; Özmen, Sevilay; Tihan, Tarik

Köy, Yazgi; Ceylan, Onur; Kahraman, Asli; Cangi, Sibel; Özmen, Sevilay; Tihan, Tarik.

Afiliação

Köy Y; Department of Pathology, Batman Teaching and Research Hospital, Batman, Turkey.
Ceylan O; Department of Pathology, Atatürk University School of Medicine, Erzurum, Turkey.
Kahraman A; Department of Pathology, Katip Çelebi University Atatürk Teaching and Research Hospital, Izmir, Turkey.
Cangi S; Department of Pathology, Gaziantep University Sahinbey Teaching and Research Hospital, Gaziantep, Turkey.
Özmen S; Department of Pathology, Atatürk University School of Medicine, Erzurum, Turkey.
Tihan T; Department of Pathology, UCSF School of Medicine, San Francisco, California, USA.

Neuropathology ; 2023 Nov 29.

Article em En | MEDLINE | ID: mdl-38029519

Palavras-chave

World Health Organization; brain tumors; central nervous system; classification; low- and middle-income countries

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neuropathology Assunto da revista: NEUROLOGIA / PATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia País de publicação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google